Allen Jeffrey Bailey

Affiliations

  • Director at Aurinia Pharmaceuticals Inc. (AUPH), 2025-05-16
  • Director at Aileron Therapeutics Inc (ALRN), 2022-06-17
  • Chief Executive Officer at Biodelivery Sciences International Inc (BDSI), 2022-03-22
  • Director at Tekla World Healthcare Fund (THW), 2021-04-08
  • Director at Tekla Healthcare Opportunities Fund (THQ), 2020-09-23
  • Director at Tekla Healthcare Investors (HQH), 2020-09-23
  • Director at Tekla Life Sciences Investors (HQL), 2020-09-23
  • Director at Landauer Inc (LDR), 2017-10-19
  • Ceo And President at Lantheus Holdings Inc. (LNTH), 2015-09-03
  • Chief Commercial Officer at King Pharmaceuticals Inc (KG), 2011-03-01
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
THW $14.18 710 $10,067.80 710 2020-09-23 Filing
THQ $17.68 570 $10,077.60 570 2020-09-23 Filing
HQH $20.39 490 $9,991.10 490 2020-09-23 Filing
HQL $17.28 580 $10,022.40 580 2020-09-22 Filing
ALRN $0.51 39,142 $19,962.42 74,894 2019-11-15 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AUPH $8.43 4,557 $38,415.51 13,356 2024-11-11 Filing
BDSI $4.35 10,000 $43,500.00 35,567 2020-12-15 Filing